Source: Neurobiology of Disease. Unidades: FORP, FMRP
Subjects: CANNABIS, CANABINOIDES, FARMACOLOGIA, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Maurício dos Santos et al. Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: possible mechanism of action. Neurobiology of Disease, v. 94, p. 179-195, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.nbd.2016.06.013. Acesso em: 22 jul. 2024.APA
Pereira, M. dos S., Silva, C. A. da, Guimarães, F. S., & Del Bel, E. A. (2016). Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: possible mechanism of action. Neurobiology of Disease, 94, 179-195. doi:10.1016/j.nbd.2016.06.013NLM
Pereira M dos S, Silva CA da, Guimarães FS, Del Bel EA. Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: possible mechanism of action [Internet]. Neurobiology of Disease. 2016 ; 94 179-195.[citado 2024 jul. 22 ] Available from: https://doi.org/10.1016/j.nbd.2016.06.013Vancouver
Pereira M dos S, Silva CA da, Guimarães FS, Del Bel EA. Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: possible mechanism of action [Internet]. Neurobiology of Disease. 2016 ; 94 179-195.[citado 2024 jul. 22 ] Available from: https://doi.org/10.1016/j.nbd.2016.06.013
